Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled “US Personalized Medicine Market Size, Trends and Insights By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, Liver, Rheumatology), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Genetics, Liquid Biopsy, Others (Predictive Modeling, Imaging)), By End-user (Hospitals, Diagnostic Centers, Research & Academic Institutes), and By Region – Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034“ in its research database.
“According to the latest research study, the demand of US Personalized Medicine Market size & share was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach a value of around USD 252.93 Billion by 2034, at a compound annual growth rate (CAGR) of about 17.32% during the forecast period 2025 to 2034.”
Click Here to Access a Free Sample Report of the US Personalized Medicine Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=72063
Overview
As per the industry experts at CMI, the U.S. personalized medicine market is poised to witness a whopping CAGR in the forecast period. This could be attributed to genomic advancements such as next-generation sequencing that facilitate more accurate diagnostics and targeted therapies. The patients are asking for more customized approaches toward healthcare, thereby resulting in higher adoption of personalized medicine. Rise in incidences of chronic diseases such as cardiovascular diseases, cancer, and diabetes is accelerating the requirement of more personalized and effective treatment strategies. Conducive government policies coupled with raised funding for research and development activities are driving innovation.
Key Trends & Drivers
- Technological Advancements and Higher Healthcare Spending to Spell Growth: Continuous advancements in data analytics, genomics, and bioinformatics are pushing the U.S. personalized medicine market forward. technologies such as CRISPR, NGS, and AI are transformingtreatment plans and diagnostics and making them more targeted as well as individualized. This innovation translates into patients’ better understanding and customizes the treatment with better results. Also, as healthcare spending increases, the government as well as private agencies continue spending more dollars on the new technologies pertaining to modern medicine as mentioned above.
Request a Customized Copy of the US Personalized Medicine Market Report @ https://www.custommarketinsights.com/request-for-customization/?reportid=72063
- Rise in Incidences of Chronic Diseases to Catalyze the U.S. Personalized Medicine Market: Chronic ailments cover conditions such as diabetes, cancer, and cardiovascular ailments. Personalized medicines are capable of being more effective in comparison with conventional types of treatment as they end up targeting the molecular and genetic basis of the conditions they address.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 66.13 Billion |
| Projected Market Size in 2034 | USD 252.93 Billion |
| Market Size in 2024 | USD 56.37 Billion |
| CAGR Growth Rate | 17.32% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Product, Application, Technology, End-user and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Country Scope | US |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
(A free sample of the US Personalized Medicine report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report.
- The …